
<DOC>
<DOCNO>
WSJ900423-0121
</DOCNO>
<DOCID>
900423-0121.
</DOCID>
<HL>
   Who's News:
   Roberts Pharmaceutical Corp.
</HL>
<DATE>
04/23/90
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE B7
</SO>
<CO>
   RPCX WNEWS
</CO>
<LP>
   ROBERTS PHARMACEUTICAL Corp. (Eatontown, N.J.) -- Yale
Brozen and A. James Sederis were elected directors of this
drug maker, increasing board membership to seven. Mr. Brozen,
a business and economics consultant, is an adjunct scholar at
the American Enterprise Institute for Public Policy Research
and a professor of business economics emeritus at the
University of Chicago's Graduate School of Business. Mr.
Sederis owns and operates a pharmaceuticals-consulting firm.
</LP>
<TEXT>
</TEXT>
</DOC>